Etoposide

About

Therapy type: Chemotherapy

Therapy strategy: Topoisomerase inhibition

Mappings

NCI Thesaurus: Etoposide (coding:ncit:C491)

RxNorm: etoposide (coding:rxcui:4179, coding:omop:1350504)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
EMA (1) CD20 + Diffuse Large B-Cell Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
EMA (1) CD20 + Non-Hodgkin Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
EMA (1) CD20 + Burkitt Lymphoma Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine
HSE (1) CD30 + Hodgkin Lymphoma Brentuximab vedotin, Cisplatin, Cytarabine, Etoposide
HSE (1) CD30 + Hodgkin Lymphoma Brentuximab vedotin, Carboplatin, Etoposide, Ifosfamide
HSE (1) CD20 + Diffuse Large B-Cell Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Non-Hodgkin Lymphoma Cyclophosphamide, Etoposide, Prednisolone, Rituximab, Vincristine
HSE (1) CD20 + Follicular Lymphoma Cyclophosphamide, Doxorubicin, Etoposide, Interferon Alpha, Prednisolone, Rituximab
EMA (1) CD30 + Hodgkin Lymphoma Brentuximab vedotin, Cyclophosphamide, Dacarbazine, Dexamethasone, Doxorubicin, Etoposide